<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Increased and decreased methylation at specific sequences (hypermethylation and hypomethylation, respectively) is characteristic of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA compared to <z:mpath ids='MPATH_458'>normal</z:mpath> DNA and promotes <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> in multiple ways including genomic instability </plain></SENT>
<SENT sid="1" pm="."><plain>Long interspersed element (LINE), an abundant class of retrotransposons, provides a surrogate marker for global hypomethylation </plain></SENT>
<SENT sid="2" pm="."><plain>We developed methylation-specific multiplex ligation-dependent probe amplification assays to study LINE-1 methylation in cases of colorectal, gastric, and <z:e sem="disease" ids="C0476089" disease_type="Neoplastic Process" abbrv="">endometrial cancer</z:e> (N = 276), stratified by patient category [<z:hpo ids='HP_0003745'>sporadic</z:hpo>; <z:e sem="disease" ids="C0009405" disease_type="Neoplastic Process" abbrv="">Lynch syndrome</z:e> (LS); familial <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> type X (FCCX)] and microsatellite instability status </plain></SENT>
<SENT sid="3" pm="."><plain>Within each patient group, LINE-1 showed lower methylation in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> DNA relative to paired <z:mpath ids='MPATH_458'>normal</z:mpath> DNA and hypomethylation was statistically significant in most cases </plain></SENT>
<SENT sid="4" pm="."><plain>Interestingly, <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa samples from different patient groups displayed differences in LINE-1 methylation that mirrored differences between the respective <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissues, with a decreasing trend for LINE-1 methylation from patients with <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> to LS to FCCX </plain></SENT>
<SENT sid="5" pm="."><plain>Despite the fact that the degree of LINE-1 methylation is generally tissue specific, <z:mpath ids='MPATH_458'>normal</z:mpath> colorectal mucosa, gastric mucosa, and endometrium from LS patients showed similar levels of LINE-1 methylation </plain></SENT>
<SENT sid="6" pm="."><plain>Our results suggest that the degree of LINE-1 methylation may constitute a "field defect" that may predispose <z:mpath ids='MPATH_458'>normal</z:mpath> tissues for <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>